ObjectiveTo investigate the possible mechanism affecting liver cirrhosis by splenectomy. MethodsBy subcutaneous administration of 20% carbon tetrachloride(CCl4), liver cirrhosis models were established in splenectomy and nonsplenectomy groups. After HE staining, special staining and immunohistochemical staining, mast cell, Kupffer’s cell and Ito cell were counted under optical microscope. Liver pathological sections and the dynamic changes of these cells in mice were studied respectively in comparison with the normal group.ResultsThe incidence of liver cirrhosis in nonsplenectomy group was significantly higher than that in splenectomy group after the 16th injection of CCl4 (P<0.05). The count of mast cell was much higher than that in splenectomy group after the 4th and the 8th injection (P<0.05). Kupffer’s cell and Ito cell significantly increased after the 12th and the 16th injection in nonsplenectomy group compared with splenectomy group (P<0.05). ConclusionSplenectomy may decline the incidence of hepatic cirrhosis caused by multifactors. In the early stage, splenectomy influences the migration, maturation and accumulation of mast cell. In the middle and late stage, it influences the proliferation of Kupper’s cell and cytokine secretion, thus the Ito cells are activated and proliferation is inhibited, in which extracellular matrix decreases in amount and the degree of hepatic fibrosis is reduced.
Citation:
PENG Jianping,YE Decun,GU Xia,LUO Jun,HE Sheng.. Study of Mechanism Affecting Liver Cirrhosis by Splenectomy. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2003, 10(3): 222-225. doi:
Copy
1. |
程明亮,刘三都主编. 肝纤维化的基础研究及临床 [M]. 北京: 人民卫生出版社,1996∶293~317.
|
2. |
陈双,杨永康,熊世钢,等.脾脏在诱发大鼠肝硬化门脉高压中的作用 [J]. 中华医学杂志,1992; 72(6)∶338.
|
3. |
汪谦,夏穗生,姜汉英,等. 脾脏在大鼠肝硬化形成过程中免疫调控机制的探讨 [J]. 中华医学杂志,1995; 75(10)∶594.
|
4. |
Farrell DJ,Hines JE,Walls AF,et al.Intrahepatic mast cells in chronic liver diseases [J].Hepatology,1995; 22(4 Pt 1)∶1175.
|
5. |
朱永红,胡大荣. 肥大细胞在感染及免疫中的作用研究进展 [J]. 国外医学免疫学分册,1999; 22(2)∶96.
|
6. |
Gordon JR,Galli SJ.Promotion of mouse fibroblast collagen gene expression by mast cells stimulated via the Fc epsilon RI. Role for mast cellderived transforming growth factor beta and tumor necrosis factor alpha [J]. J Exp Med,1994; 180(6)∶2027.
|
7. |
张志勇,阮幼冰,武忠弼. 转化生长因子β1及其受体在大鼠肝纤维化肥大细胞的表达 [J]. 中华病理学杂志,2000; 29(4)∶295.
|
8. |
常文建,陆贯一. 枯否细胞和肝脏缺血再灌注损伤 [J]. 中国普外基础与临床杂志,2001; 8(4)∶276.
|
9. |
Kubo S,Rodriguez T Jr,Roh MS,et al.Stimulation of phagocytic activity of murine Kupffer cells by Tuftsin [J].Hepatology,1994; 19(4)∶1044.
|
10. |
汪谦, 夏穗生, 姜汉英, 等. 脾脏及促吞噬肽在体外肝细胞培养过程的免疫调控作用 [J]. 中华实验外科杂志, 1995; 12(5)∶314.
|
- 1. 程明亮,刘三都主编. 肝纤维化的基础研究及临床 [M]. 北京: 人民卫生出版社,1996∶293~317.
- 2. 陈双,杨永康,熊世钢,等.脾脏在诱发大鼠肝硬化门脉高压中的作用 [J]. 中华医学杂志,1992; 72(6)∶338.
- 3. 汪谦,夏穗生,姜汉英,等. 脾脏在大鼠肝硬化形成过程中免疫调控机制的探讨 [J]. 中华医学杂志,1995; 75(10)∶594.
- 4. Farrell DJ,Hines JE,Walls AF,et al.Intrahepatic mast cells in chronic liver diseases [J].Hepatology,1995; 22(4 Pt 1)∶1175.
- 5. 朱永红,胡大荣. 肥大细胞在感染及免疫中的作用研究进展 [J]. 国外医学免疫学分册,1999; 22(2)∶96.
- 6. Gordon JR,Galli SJ.Promotion of mouse fibroblast collagen gene expression by mast cells stimulated via the Fc epsilon RI. Role for mast cellderived transforming growth factor beta and tumor necrosis factor alpha [J]. J Exp Med,1994; 180(6)∶2027.
- 7. 张志勇,阮幼冰,武忠弼. 转化生长因子β1及其受体在大鼠肝纤维化肥大细胞的表达 [J]. 中华病理学杂志,2000; 29(4)∶295.
- 8. 常文建,陆贯一. 枯否细胞和肝脏缺血再灌注损伤 [J]. 中国普外基础与临床杂志,2001; 8(4)∶276.
- 9. Kubo S,Rodriguez T Jr,Roh MS,et al.Stimulation of phagocytic activity of murine Kupffer cells by Tuftsin [J].Hepatology,1994; 19(4)∶1044.
- 10. 汪谦, 夏穗生, 姜汉英, 等. 脾脏及促吞噬肽在体外肝细胞培养过程的免疫调控作用 [J]. 中华实验外科杂志, 1995; 12(5)∶314.